Back
ResMed 10K Form
Sell
49
RMD
ResMed
Last Price:
242.00
Seasonality Move:
9.06%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2023-10-27 | 10Q | RMD/ResMed Quarterly |
| 2023-04-28 | 10Q | RMD/ResMed Quarterly |
| 2023-01-27 | 10Q | RMD/ResMed Quarterly |
| 2022-10-28 | 10Q | RMD/ResMed Quarterly |
| 2022-04-29 | 10Q | RMD/ResMed Quarterly |
| 2022-01-28 | 10Q | RMD/ResMed Quarterly |
Receive RMD News And Ratings
See the #1 stock for the next 7 days that we like better than RMD
RMD Financial Statistics
Sales & Book Value
| Annual Sales: | $4.69B |
|---|---|
| Cash Flow: | $305.93M |
| Price / Cash Flow: | 26.23 |
| Annual Sales: | $35.39 |
| Price / Book: | 6.77 |
Profitability
| EPS (TTM): | 7.55000 |
|---|---|
| Net Income (TTM): | $1.11B |
| Gross Margin: | $2.66B |
| Return on Equity: | 23.76% |
| Return on Assets: | 16.1% |
ResMed Earnings Forecast
Key ResMed Financial Ratios
- The Gross Profit Margin over the past 32 years for RMD is 56.67%.
- The Selling, General & Administrative Expenses for RMD have been equal to 19.57% of Gross Profit Margin.
- The Research & Development expenses have been 6.56% of Revenue.
- The Interest Expense is 4.48% of Operating Income.
- The Net Earning history of RMD is 21.79% of Total Revenues.
- Per Share Earnings over the last 32 years have been positive in 24 years.
ResMed Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Health Care Equipment & Supplies |
| Sector: | Health Care |
| Current Symbol: | RMD |
| CUSIP: | 761152 |
| Website: | resmed.com |
Debt
| Debt-to-Equity Ratio: | 0.13 |
|---|---|
| Current Ratio: | 2.92 |
| Quick Ratio: | 1.37 |
Price-to-Earnings
| Trailing P/E Ratio: | 34.6 |
|---|---|
| Forward P/E Ratio: | 23.29 |